Effectiveness of Electroconvulsive Therapy (ECT) in Parkinsonian Symptoms: A Case Series

We describe their treatment and review the current literature on the use of ECT among patients with PD. CASE SERIES All six patients in our retrospective chart review received bitemporal modified brief pulse ECT. Prior to ECT, the patients underwent pre-ECT evaluation, which involved hemogram analysis, renal and liver function tests, fasting blood glucose analysis, chest X-ray (posteroanterior view), and serum electrolyte analysis, all of which were within the normal range for all six patients, and none of the patients showed evidence of raised intracranial pressure on fundoscopy examination. All patients provided written informed consent prior to starting ECT. Glycopyrrolate was used as a premedication, thiopentone was used for induction, and suxamethonium was used for muscle relaxation. Motor seizure of at least 15 seconds was considered effective. Details of different parameters are provided in Table 1. Case 1. Mr. A, 56 years old, presented with a nine-year history of PD with recurrent depressive disorder (as per International Classification of Diseases, 10th Revision [ICD-10]). His medications included levodopa-carbidopa-entacapone, trihexyphenidyl, baclofen, rasageline, and mirtazapine. The patient reported that he had been experiencing a worsening of PD symptoms (e.g., increase in rigidity and tremors) and the need for assistance with activities of daily living (ADL)for the three months prior to presentation to our clinic, despite being on regular treatment. During th...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Case Review Current Issue Depression Devices ECT Mental Disorders Mood Disorders Movement Disorders Neurology Parkinson's disease Psychiatry Technology Electroconvulsive therapy parkinson’s disease Source Type: research